Gotto, G. . (2020) “Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC”, Canadian Urological Association Journal, 14(12), pp. E616–20. doi: 10.5489/cuaj.6388.